Bullish MAXCP Stocks
9/16/2014
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis
Marketwired
(Tue, Sep 9)
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference
Marketwired
(Fri, Sep 5)